The Japanese Journal of Antibiotics
Online ISSN : 2186-5477
Print ISSN : 0368-2781
ISSN-L : 0368-2781
COMBINED THERAPY WITH ARBEKACIN AND FOSFOMYCIN FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS
KENJI KONOSEIJI TAKEDAICHIRO TATARAKIKUO ARAKAWAHIROAKI TANAKASHUNJI MIYAKEHIROMICHI MINAMIKAWAHIROSUKE HOSHINOMIKIO SATOFUMITADA HATTORIKOZABURO KAWAHIRA
Author information
JOURNAL FREE ACCESS

1994 Volume 47 Issue 6 Pages 798-803

Details
Abstract

We examined the clinical efficacy of a combination of arbekacin and fosfomycin in the treatment of various methicillin-resistant Staphylococcus aureus (MRSA) infections. The combination ofarbekacin plus fosfomycin displayed 65.4% (17/26) clinical efficacy and 65.4% (17/26) bacteriological efficacy. This combination thus appeared to be an effective regimen for the treatment of MRSA infections. However, its bacteriological efficacy against concomitant Pseudomonas aeruginosa strains was only 16.7% (1/6). In addition, in 4 episodes of superinfection involving P. aeruginosa strains developed during the combination therapy.

Content from these authors
© Japan Antibiotics Research Association
Previous article Next article
feedback
Top